2025 · 2nd Quarter (Apr 1 - June 30)
Filed by LMH STRATEGIC SOLUTIONS.
Open official filingSource-reported fields
Literal source text
Legislation issues impacting PTC Therapeutics, including: H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. MVP Act. Tax Relief for American Families and Workers Act. American Innovation and Jobs Act. ORPHAN Cures Act. American Innovation and R&D Competitiveness Act. Camerons Law.
Literal federal measure citations: H.R.1492
Legislation issues impacting PTC Therapeutics, including: H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. MVP Act. Tax Relief for American Families and Workers Act. American Innovation and Jobs Act. ORPHAN Cures Act. American Innovation and R&D Competitiveness Act. Camerons Law.
Literal federal measure citations: H.R.1492
Legislation issues impacting PTC Therapeutics, including: H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. MVP Act. Tax Relief for American Families and Workers Act. American Innovation and Jobs Act. ORPHAN Cures Act. American Innovation and R&D Competitiveness Act. Camerons Law.
Literal federal measure citations: H.R.1492
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.
